Candel Therapeutics Appoints Maha Radhakrishnan, M.D., to its Board of Directors


Appointment of seasoned strategic industry executive strengthens the Board of Directors as Candel advances toward Biologics License Application submission and commercial development Appointment of seasoned strategic industry executive strengthens the Board of Directors as Candel advances toward Biologics License Application submission and commercial development

Go here to read the rest:
Candel Therapeutics Appoints Maha Radhakrishnan, M.D., to its Board of Directors

Related Posts